Matches in SemOpenAlex for { <https://semopenalex.org/work/W2567683646> ?p ?o ?g. }
- W2567683646 endingPage "33896" @default.
- W2567683646 startingPage "33884" @default.
- W2567683646 abstract "// Jie Lin 1,* , Guozhu Xie 1,* , Guixiang Liao 3 , Baiyao Wang 1 , Miaohong Yan 1 , Hui Li 1 and Yawei Yuan 1,2 1 Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China 2 Department of Radiation Oncology, Cancer Center of Guangzhou Medical University, Guangzhou, Guangdong, China 3 Department of Radiation Oncology, Shenzhen people’s Hospital, Second Clinical Medicine College of Jinan University, Guangzhou, Guangdong, China * These authors have contributed equally to this work Correspondence to: Yawei Yuan, email: // Keywords : 18F-FDG PET/CT, standardized uptake value, metabolic tumor volume, total lesion glycolysis, nasopharyngeal carcinoma Received : July 29, 2016 Accepted : December 06, 2016 Published : December 14, 2016 Abstract Background: The prognostic role of 18 F-fluorodeoxyglucose positron emission tomography CT ( 18 F-FDG PET/CT) parameters is still controversial in nasopharyngeal carcinoma patients. We sought to perform a systematic review and meta-analysis to explore the prognostic value of maximal standardized uptake value (SUV max ), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) on event-free survival (EFS) and overall survival (OS) in nasopharyngeal carcinoma patients. Results: Fifteen studies comprising 1,938 patients were included in this study. The combined hazard ratios (HRs) for EFS were 2.63 (95%CI 1.71-4.05) for SUV max , 2.55 (95%CI 1.49-4.35) for MTV, and 3.32 (95%CI 1.23-8.95) for TLG. The pooled HRs for OS were 2.07 (95%CI 1.54-2.79) for SUV max , 3.86 (95%CI 1.85-8.06) for MTV, and 2.60 (95%CI 1.55-4.34) for TLG. The prognostic role of SUV max , MTV and TLG remained similar in the sub-group analyses. Methods: A systematic literature search was performed to identify studies which associated 18 F-FDG PET/CT to clinical survival outcomes of nasopharyngeal carcinoma patients. The summarized HRs for EFS and OS were estimated by using fixed- or random-effect models according to heterogeneity between trials. Conclusions: The present meta-analysis confirms that high values of SUV max , MTV and TLG predicted a higher risk of adverse events or death in patients with nasopharyngeal carcinoma, despite clinically heterogeneous nasopharyngeal carcinoma patients and the various methods adopted between these studies." @default.
- W2567683646 created "2017-01-06" @default.
- W2567683646 creator A5001960617 @default.
- W2567683646 creator A5023550980 @default.
- W2567683646 creator A5037968408 @default.
- W2567683646 creator A5051251413 @default.
- W2567683646 creator A5056810676 @default.
- W2567683646 creator A5085468650 @default.
- W2567683646 creator A5091395657 @default.
- W2567683646 date "2016-12-14" @default.
- W2567683646 modified "2023-09-29" @default.
- W2567683646 title "Prognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis" @default.
- W2567683646 cites W1766290423 @default.
- W2567683646 cites W1876297322 @default.
- W2567683646 cites W1952424369 @default.
- W2567683646 cites W1968456152 @default.
- W2567683646 cites W1969746706 @default.
- W2567683646 cites W1971385035 @default.
- W2567683646 cites W1976902751 @default.
- W2567683646 cites W1982142916 @default.
- W2567683646 cites W1985656391 @default.
- W2567683646 cites W1987473753 @default.
- W2567683646 cites W1993596510 @default.
- W2567683646 cites W1994397875 @default.
- W2567683646 cites W1995799724 @default.
- W2567683646 cites W2001624590 @default.
- W2567683646 cites W2002812871 @default.
- W2567683646 cites W2006698510 @default.
- W2567683646 cites W2008102854 @default.
- W2567683646 cites W2016090566 @default.
- W2567683646 cites W2018261701 @default.
- W2567683646 cites W2021978238 @default.
- W2567683646 cites W2027325737 @default.
- W2567683646 cites W2028896946 @default.
- W2567683646 cites W2031160860 @default.
- W2567683646 cites W2035615604 @default.
- W2567683646 cites W2044843027 @default.
- W2567683646 cites W2045545750 @default.
- W2567683646 cites W2057136974 @default.
- W2567683646 cites W2058266571 @default.
- W2567683646 cites W2059769860 @default.
- W2567683646 cites W2075642745 @default.
- W2567683646 cites W2075660225 @default.
- W2567683646 cites W2076424996 @default.
- W2567683646 cites W2077911118 @default.
- W2567683646 cites W2081447305 @default.
- W2567683646 cites W2088095316 @default.
- W2567683646 cites W2088783247 @default.
- W2567683646 cites W2092074766 @default.
- W2567683646 cites W2100210297 @default.
- W2567683646 cites W2103308645 @default.
- W2567683646 cites W2103484891 @default.
- W2567683646 cites W2105656190 @default.
- W2567683646 cites W2112269002 @default.
- W2567683646 cites W2116674500 @default.
- W2567683646 cites W2119325900 @default.
- W2567683646 cites W2128506849 @default.
- W2567683646 cites W2128646736 @default.
- W2567683646 cites W2132318011 @default.
- W2567683646 cites W2134235092 @default.
- W2567683646 cites W2140041771 @default.
- W2567683646 cites W2144961030 @default.
- W2567683646 cites W2147675557 @default.
- W2567683646 cites W2150591403 @default.
- W2567683646 cites W2153576017 @default.
- W2567683646 cites W2163801398 @default.
- W2567683646 cites W2167718617 @default.
- W2567683646 cites W2171719821 @default.
- W2567683646 cites W2173214582 @default.
- W2567683646 cites W2191981783 @default.
- W2567683646 cites W2204338758 @default.
- W2567683646 cites W2210744057 @default.
- W2567683646 cites W2236634599 @default.
- W2567683646 cites W2255479212 @default.
- W2567683646 cites W2277633585 @default.
- W2567683646 cites W2282315360 @default.
- W2567683646 cites W2294343723 @default.
- W2567683646 cites W2323373325 @default.
- W2567683646 cites W2323625474 @default.
- W2567683646 cites W2334616195 @default.
- W2567683646 cites W2345421337 @default.
- W2567683646 cites W2411272947 @default.
- W2567683646 cites W2413430220 @default.
- W2567683646 cites W2442763073 @default.
- W2567683646 cites W2611393816 @default.
- W2567683646 cites W2917746472 @default.
- W2567683646 cites W3191734867 @default.
- W2567683646 cites W4210983491 @default.
- W2567683646 cites W591589048 @default.
- W2567683646 cites W92388963 @default.
- W2567683646 doi "https://doi.org/10.18632/oncotarget.13934" @default.
- W2567683646 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5464920" @default.
- W2567683646 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27980228" @default.
- W2567683646 hasPublicationYear "2016" @default.
- W2567683646 type Work @default.
- W2567683646 sameAs 2567683646 @default.
- W2567683646 citedByCount "32" @default.
- W2567683646 countsByYear W25676836462017 @default.